These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21310125)

  • 1. [Current condition and advances in the target treatment of lung cancer].
    Zhou Q
    Zhongguo Fei Ai Za Zhi; 2003 Dec; 6(6):434-40. PubMed ID: 21310125
    [No Abstract]   [Full Text] [Related]  

  • 2. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
    Hirsch FR; Franklin WA; Gazdar AF; Bunn PA
    Clin Cancer Res; 2001 Jan; 7(1):5-22. PubMed ID: 11205917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of lung cancer.
    Carney DN
    Curr Opin Pulm Med; 1995 Jul; 1(4):271-7. PubMed ID: 9363064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes and current state of diagnosis of lung cancer after development of the flexible bronchofiberscope.
    Kaneko M
    Jpn J Clin Oncol; 2010 Sep; 40(9):838-45. PubMed ID: 20736220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in diagnosis and treatment of lung cancer].
    Watanabe Y
    Nihon Rinsho; 2000 May; 58(5):993-8. PubMed ID: 10824538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non small cell lung cancer (NSCLC): current status and future prospects.
    Pathak AK; Bhutani M; Mohan A; Guleria R; Bal S; Kochupillai V
    Indian J Chest Dis Allied Sci; 2004; 46(3):191-203. PubMed ID: 15553208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in immunosuppression for lung transplantation.
    Floreth T; Bhorade SM
    Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor as a target to improve treatment of lung cancer.
    Andratschke NH; Dittmann KH; Mason KA; Fan Z; Liao Z; Komaki R; Ang KK; Milas L
    Clin Lung Cancer; 2004 May; 5(6):340-52. PubMed ID: 15217533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in imaging: target delineation.
    Hunter KU; Eisbruch A
    Cancer J; 2011; 17(3):151-4. PubMed ID: 21610467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
    Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in non-small cell lung cancer.
    Walker S
    Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of angiogenesis in lung cancer and its metastases].
    Yano S; Sone S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2131-8. PubMed ID: 10635295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil on the expression of EGFR and NM23 in A549 human lung cancer cells.
    Zhang C; Lv F; Zhou L; Li X; Wu XX; Hoffman RM
    Anticancer Res; 2009 Jan; 29(1):27-32. PubMed ID: 19331130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Guidelines for the Management of Lung Cancer and evaluation from clinical practice].
    Morikawa T
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):237-41. PubMed ID: 17907451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy for non-small cell lung cancer.
    Toloza EM; D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of lung cancer: an update.
    Rüttinger D; Winter H; van den Engel NK; Hatz RA; Schlemmer M; Pohla H; Grützner S; Schendel DJ; Fox BA; Jauch KW
    Onkologie; 2006 Feb; 29(1-2):33-8. PubMed ID: 16514254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions in the treatment of non-small cell lung cancer.
    Shepherd FA
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):48-62. PubMed ID: 8209277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.